Piramal Pharma gets EIR from USFDA for Sellersville, USA facility

Piramal Pharma Limited has announced that the US FDA has issued an Establishment Inspection Report (EIR) for the manufacturing facility located at Sellersville, USA and the inspection has now been successfully closed by the US FDA.

Shares of Piramal Pharma Limited was last trading in BSE at Rs. 71.46 as compared to the previous close of Rs. 71.53. The total number of shares traded during the day was 187124 in over 1591 trades.

The stock hit an intraday high of Rs. 72.43 and intraday low of 70.96. The net turnover during the day was Rs. 13414836.00.

Source : Equity Bulls

Keywords

PiramalPharma PPLPHARMA INE0DK501011 Pharmaceuticals EIR USFDA Sellersville USA ManufacturingFacility